Orexo AB (publ) (FRA:C5G)

Germany flag Germany · Delayed Price · Currency is EUR
2.400
-0.020 (-0.83%)
At close: Feb 20, 2026
Market Cap88.49M +60.5%
Revenue (ttm)2.40M -95.6%
Net Income59.07M
EPS1.71
Shares Outn/a
PE Ratio1.50
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volumen/a
Average Volume0
Open2.400
Previous Close2.420
Day's Range2.400 - 2.400
52-Week Range1.092 - 3.825
Betan/a
RSI36.56
Earnings DateFeb 5, 2026

About Orexo AB

Orexo AB (publ), a specialty pharmaceutical company, develops and commercializes pharmaceuticals and digital therapies in the United States, European Union, the United Kingdom, and internationally. Its products include Zubsolv tablets for the treatment of opioid use disorder; Abstral for the treatment of breakthrough pain in cancer patients; and Edluar for the treatment of insomnia. The company is developing OX124 for opioid overdose; OX125 for rescue medication and opioid overdose; OX640 to treat anaphylaxis with powder-based epinephrine; and ... [Read more]

Industry Pharmaceutical Preparations
Founded 1994
Employees 72
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol C5G
Full Company Profile

Financial Performance

Financial numbers in SEK Financial Statements